Office of Pharmacovigilance, Guangzhou Baiyunshan Pharmaceutical Holding Co. Ltd., Baiyunshan Pharmaceutical General Factory, Guangzhou, Guangdong Province, China.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2229704. doi: 10.1080/21645515.2023.2229704.
In accordance with the COVID-19 surveillance data from Hong Kong, over 95% fatal cases were elderly patients aged ≥60 years, and the median age of the dead cases was 86 years in the fifth COVID-19 wave. COVID-19 case fatality rates increased with age, vaccinations offered notable protection against COVID-19 death, and the protection was enhanced as the doses of vaccinations increased. The data fully demonstrated that elderly people were the main group of victims in the COVID-19 pandemic, and the vaccination was a vital weapon against COVID-19 in elderly people. In light of the experience of China's COVID-19 response, the measures to improve COVID-19 vaccination coverage in older people were shown as follows: dispatching volunteers into residential communities to urge older people to complete COVID-19 vaccinations; ascertaining the vaccination status of elderly people suffering from underlying diseases; mobilizing various public institutions to participate in COVID-19 response; releasing a great deal of news via mass media every day to educate the elderly about COVID-19 prevention and control measures; assisting elderly people in rural and remote areas through drug distribution and emergency reserves.
根据香港的 COVID-19 监测数据,超过 95%的死亡病例为年龄≥60 岁的老年患者,第五波 COVID-19 中死亡病例的中位数年龄为 86 岁。COVID-19 的病死率随年龄增长而上升,疫苗接种对 COVID-19 死亡提供显著保护,且随着接种剂量的增加保护作用增强。这些数据充分表明老年人是 COVID-19 大流行的主要受害群体,接种疫苗是老年人对抗 COVID-19 的重要武器。借鉴中国应对 COVID-19 的经验,提高老年人 COVID-19 疫苗接种覆盖率的措施包括:派遣志愿者进入居民区,督促老年人完成 COVID-19 疫苗接种;确定患有基础疾病的老年人的疫苗接种状况;动员各种公共机构参与 COVID-19 应对;通过大众媒体每天发布大量新闻,向老年人宣传 COVID-19 防控措施;通过药品分发和应急储备,为农村和偏远地区的老年人提供帮助。